BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 20928895)

  • 21. Enantiomeric fluoro-substituted benzothiazole Schiff base-valine Cu(II)/Zn(II) complexes as chemotherapeutic agents: DNA binding profile, cleavage activity, MTT assay and cell imaging studies.
    Alizadeh R; Yousuf I; Afzal M; Srivastav S; Srikrishna S; Arjmand F
    J Photochem Photobiol B; 2015 Feb; 143():61-73. PubMed ID: 25600265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo design, synthesis and spectroscopic characterization of chiral benzimidazole-derived amino acid Zn(II) complexes: Development of tryptophan-derived specific hydrolytic DNA artificial nuclease agent.
    Parveen S; Arjmand F
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Jan; 85(1):53-60. PubMed ID: 22000640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and synthesis of (S)- and (R)-enantiomers of [4-(2-hydroxy-1-phenylethylimino)pent-2-ol]dimethyltin(iv) and 2,2-dimethyl-4-phenyl-1,3,2-oxazastannolidine: in vitro antitumor activity against human tumor cell lines and in vivo assay of (S)-enantiomers.
    Arjmand F; Sayeed F; Parveen S; Tabassum S; Juvekar AS; Zingde SM
    Dalton Trans; 2013 Mar; 42(10):3390-401. PubMed ID: 23250651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, characterization, interaction with DNA and cytotoxicity in vitro of novel pyridine complexes with Zn(II).
    Gao EJ; Sun TD; Liu SH; Ma S; Wen Z; Wang Y; Zhu MC; Wang L; Gao XN; Guan F; Guo MJ; Liu FC
    Eur J Med Chem; 2010 Oct; 45(10):4531-8. PubMed ID: 20692739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA binding, prominent DNA cleavage and efficient anticancer activities of tris(diimine)iron(II) complexes.
    Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
    Dalton Trans; 2011 Apr; 40(14):3524-36. PubMed ID: 21369607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and characterization of the ligand based on benzoxazole and its transition metal complexes: DNA-binding and antitumor activity.
    Jiang J; Tang X; Dou W; Zhang H; Liu W; Wang C; Zheng J
    J Inorg Biochem; 2010 May; 104(5):583-91. PubMed ID: 20202687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biophysical studies of bis-macrocyclic cobalt/copper(II) complexes having a pyridine spacer with CT DNA and 5'-GMP.
    Arjmand F; Aziz M
    Chem Biodivers; 2009 Dec; 6(12):2275-89. PubMed ID: 20020459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New modulated design and synthesis of chiral CuII/SnIV bimetallic potential anticancer drug entity: in vitro DNA binding and pBR322 DNA cleavage activity.
    Tabassum S; Sharma GC; Arjmand F
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 May; 90():208-17. PubMed ID: 22343081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of rac-[Cu(diimine)3]2+ and rac-[Zn(diimine)3]2+ complexes with CT DNA: effect of fluxional Cu(II) geometry on DNA binding, ligand-promoted exciton coupling and prominent DNA cleavage.
    Ramakrishnan S; Palaniandavar M
    Dalton Trans; 2008 Aug; (29):3866-78. PubMed ID: 18629409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An effective approach to artificial nucleases using copper(II) complexes bearing nucleobases.
    Wang JT; Xia Q; Zheng XH; Chen HY; Chao H; Mao ZW; Ji LN
    Dalton Trans; 2010 Feb; 39(8):2128-36. PubMed ID: 20148233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, characterization and in vitro DNA binding and cleavage studies of Cu(II)/Zn(II) dipeptide complexes.
    Arjmand F; Jamsheera A; Mohapatra DK
    J Photochem Photobiol B; 2013 Apr; 121():75-85. PubMed ID: 23518161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural, electrochemical, phosphate-hydrolysis, DNA binding and cleavage studies of new macrocyclic binuclear nickel(II) complexes.
    Anbu S; Kandaswamy M; Varghese B
    Dalton Trans; 2010 Apr; 39(16):3823-32. PubMed ID: 20372706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ternary copper(II)-polypyridyl enantiomers: aldol-type condensation, characterization, DNA-binding recognition, BSA-binding and anticancer property.
    Ng CH; Wang WS; Chong KV; Win YF; Neo KE; Lee HB; San SL; Raja Abd Rahman RN; Leong WK
    Dalton Trans; 2013 Jul; 42(28):10233-43. PubMed ID: 23728518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA binding and antiproliferative activity toward human carcinoma cells of copper(II) and zinc(II) complexes of a 2,5-diphenyl[1,3,4]oxadiazole derivative.
    Terenzi A; Fanelli M; Ambrosi G; Amatori S; Fusi V; Giorgi L; Turco Liveri V; Barone G
    Dalton Trans; 2012 Apr; 41(15):4389-95. PubMed ID: 22333893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Copper(II) complexes of salicylic acid combining superoxide dismutase mimetic properties with DNA binding and cleaving capabilities display promising chemotherapeutic potential with fast acting in vitro cytotoxicity against cisplatin sensitive and resistant cancer cell lines.
    O'Connor M; Kellett A; McCann M; Rosair G; McNamara M; Howe O; Creaven BS; McClean S; Kia AF; O'Shea D; Devereux M
    J Med Chem; 2012 Mar; 55(5):1957-68. PubMed ID: 22313179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxovanadium(IV) complexes of phenanthroline bases: the dipyridophenazine complex as a near-IR photocytotoxic agent.
    Sasmal PK; Saha S; Majumdar R; De S; Dighe RR; Chakravarty AR
    Dalton Trans; 2010 Feb; 39(8):2147-58. PubMed ID: 20148235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and crystal structure elucidation of new copper(II)-based chemotherapeutic agent coupled with 1,2-DACH and orthovanillin: Validated by in vitro DNA/HSA binding profile and pBR322 cleavage pathway.
    Zaki M; Afzal M; Ahmad M; Tabassum S
    J Photochem Photobiol B; 2016 Aug; 161():318-27. PubMed ID: 27289445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, crystal structure and biological activities of a novel amidrazone derivative and its copper(II) complex--a potential antitumor drug.
    Mazur L; Modzelewska-Banachiewicz B; Paprocka R; Zimecki M; Wawrzyniak UE; Kutkowska J; Ziółkowska G
    J Inorg Biochem; 2012 Sep; 114():55-64. PubMed ID: 22694858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Four new dinuclear Cu(ii) hydrazone complexes using various organic spacers: syntheses, crystal structures, DNA binding and cleavage studies and selective cell inhibitory effect towards leukemic and normal lymphocytes.
    Banerjee S; Mondal S; Sen S; Das S; Hughes DL; Rizzoli C; Desplanches C; Mandal C; Mitra S
    Dalton Trans; 2009 Sep; (34):6849-60. PubMed ID: 19690698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, characterization, DNA binding and cleavage, BSA interaction and anticancer activity of dinuclear zinc complexes.
    Gao CY; Qiao X; Ma ZY; Wang ZG; Lu J; Tian JL; Xu JY; Yan SP
    Dalton Trans; 2012 Oct; 41(39):12220-32. PubMed ID: 22930131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.